Menopausal hormone therapy is one of the treatment options considered for women whose daily lives are affected by symptoms such as hot flashes, night sweats, disrupted sleep, and vaginal dryness, for women at risk of osteoporosis, and for women who enter early menopause before age 45. Hormone therapy is not given to everyone in the same way. It is sometimes given as hormone replacement therapy, particularly for women with early menopause or premature ovarian insufficiency. Whether treatment is suitable is assessed according to age, time since menopause, whether the woman still has her uterus, personal health history, and the route by which the hormone is given.

Some of the most common concerns about menopausal hormone therapy are the risks of cancer, stroke, and blood clots. These risks should not be ignored, but they should not be considered the same for all hormone therapies and all women. Today, the type of treatment, when it is started, whether estrogen is given by mouth or through the skin, and whether a progestogen (a progestin (synthetic progesterone) or progesterone) is needed are each assessed separately.

In healthy women with significant menopausal symptoms, particularly those younger than 60 or within the first 10 years after the onset of menopause, the benefit-risk balance of hormone therapy is often considered more favorable.

Who May Be a Candidate for Menopausal Hormone Therapy?

Menopausal hormone therapy is most often considered for women with prominent vasomotor symptoms such as hot flashes and night sweats. However, vaginal dryness, burning, and menopause-related genitourinary symptoms are also important reasons for treatment. In suitable women, it also helps reduce bone loss after menopause.

Middle-aged woman in a pink jacket sitting in an armchair, explaining who menopausal hormone therapy may suit

The decision to treat is not based solely on being in menopause. How much the symptoms affect daily life, the woman's age, the time since menopause, breast and uterine health, history of blood clots, and cardiovascular risks are all considered together.

Hormone therapy is now also recommended before menopause, in the perimenopausal period, once symptoms begin.

When Treatment Is Started General Assessment
Under 60, or within the first 10 years after menopause In suitable women, the benefit-risk balance is generally more favorable
Over 60, and more than 10 years since menopause The treatment decision requires a more detailed, individual risk assessment
Women with vaginal symptoms only Local vaginal treatment may be sufficient instead of systemic therapy

The table shows the general approach; age alone does not determine whether a woman is a candidate for treatment.

Why Are the First 10 Years After Menopause Important?

The timing of initiation matters in menopausal hormone therapy. Starting treatment in early menopause and starting it for the first time at a much older age do not carry the same risk profile.

For this reason, hormone therapy is more often considered for women with significant hot flashes or night sweats who are younger than 60 or less than 10 years past menopause. When treatment is started for the first time at an older age, personal risks of cardiovascular disease, stroke, and blood clots need to be assessed in more detail.

Which Symptoms Does Menopausal Hormone Therapy Help With?

The most notable benefit of hormone therapy is seen in hot flashes and night sweats, known as the vasomotor symptoms of menopause. It can also be used for menopause-related vaginal and urinary symptoms and to prevent bone loss.

The expected benefit of treatment can vary from person to person. For this reason, it is not accurate to view hormone therapy as a method that eliminates all menopausal symptoms or stops aging.

Does Hormone Therapy Reduce Hot Flashes and Night Sweats?

Yes. Menopausal hormone therapy is one of the most effective treatment options for reducing hot flashes and night sweats. In women who wake up frequently because of night sweats in particular, the reduction in symptoms can also indirectly improve sleep patterns.

The frequency and severity of symptoms are important in deciding whether treatment is needed. A woman with hot flashes that occur several times a day and significantly disrupt her work life or nighttime sleep may not have the same need for treatment as a woman with mild, infrequent symptoms.

Does Hormone Therapy Affect Sleep and Mood?

During menopause, night sweats and hot flashes can cause frequent sleep disruption. Bringing these symptoms under control can help improve sleep quality.

Mood changes can also occur during menopause, but hormone therapy is not a treatment for every case of depression or anxiety. With significant and persistent psychological symptoms, other causes should be evaluated in addition to any link with menopausal symptoms.

Does Hormone Therapy Help With Vaginal Dryness?

Declining estrogen can cause vaginal dryness, burning, tenderness, and pain during intercourse. In some women, these symptoms affect not only sexual life but also the urinary tract.

For women with vaginal symptoms only, local vaginal estrogen may be preferred over systemic hormone therapy, which affects the whole body. In local treatment, the hormone acts mainly on the vaginal and surrounding tissues and is considered differently from systemic hormone therapy.

Does Hormone Therapy Prevent Bone Loss?

The decline in estrogen levels with menopause can accelerate bone loss. In suitable women, hormone therapy can help reduce bone loss and lower the risk of fractures.

However, the decision on hormone therapy is not made based on bone health alone. Osteoporosis risk, age, other treatment options, and whether menopausal symptoms are present are all considered together.

Does Hormone Therapy Cause Weight Loss or Stop Aging?

No. Menopausal hormone therapy is not a weight-loss treatment and does not stop aging. Routine hormone therapy is not recommended for hair loss, skin aging, or general rejuvenation.

During menopause, weight changes are influenced by a combination of age, muscle mass, diet, sleep, physical activity, and metabolic factors. The main goal of hormone therapy is to control significant menopause-related symptoms.

Indeed, menopausal hormone therapy (MHT) is not a weight-loss treatment. However, body fat distribution can change with the menopausal transition: unlike the subcutaneous fat seen mostly on the hips and thighs during the reproductive years, an increase in abdominal and visceral fat may become more pronounced after menopause. This change, which develops along with declining estrogen, aging, and lifestyle changes, is associated with cardiometabolic risks such as insulin resistance, dyslipidemia, hypertension, and metabolic syndrome. Menopausal hormone therapy should not be used for weight loss; however, there is evidence that in suitable patients, while treating estrogen deficiency, it may reduce to some extent abdominal/visceral fat accumulation and adverse changes in glucose-insulin metabolism. For this reason, evaluation during menopause should focus not only on the number on the scale but also on waist circumference, body composition, and overall cardiometabolic risks.

Why Are Estrogen and Progesterone Used Together in Menopause?

The content of menopausal hormone therapy depends on whether the woman still has her uterus. Estrogen is the key hormone for controlling menopausal symptoms. However, in a woman who has a uterus, using systemic estrogen alone for a long time can overstimulate the lining of the uterus.

For this reason, in women who have a uterus, a progestogen, meaning progesterone or a progestin (synthetic progesterone), is usually added to systemic estrogen.

Why Is Progesterone Needed in Women Who Have a Uterus?

While estrogen relieves menopausal symptoms, it also stimulates the lining of the uterus, the endometrium. If systemic estrogen is used alone for a long time in a woman who has a uterus, this lining can become thicker than it should. Over time, this can lead to cellular changes and an increased risk of endometrial cancer.

Progesterone or similar progestogens balance this stimulating effect of estrogen on the uterine lining. In other words, progesterone helps prevent uncontrolled thickening of the endometrium.

For this reason, when systemic menopausal hormone therapy is planned for women who have a uterus, progesterone is usually added to the estrogen. Progesterone can be taken continuously or on certain days of the month. Which regimen is appropriate is determined according to the stage of menopause, the bleeding pattern, and the treatment chosen.

Can Estrogen Alone Be Used in Women Who Have Had a Hysterectomy?

In women whose uterus has been completely removed surgically, there is no endometrium, so in most cases progesterone does not need to be added and estrogen-only therapy can be used.

However, the reason for the surgery, any history of endometriosis, and the woman's other health characteristics may be taken into account when choosing treatment. So having had a hysterectomy does not mean that treatment becomes completely standard.

Smiling middle-aged woman speaking, explaining estrogen-only therapy for women who have had a hysterectomy

How Is Menopausal Hormone Therapy Given?

Menopausal hormone therapy can be given as oral tablets, as a gel or patch applied to the skin, or as vaginal products. The route of administration affects not only convenience but also certain risks.

Route of Administration Area of Effect Key Feature
Oral tablet Systemic Acts throughout the body; undergoes first-pass metabolism in the liver
Transdermal gel or patch Systemic Largely bypasses first-pass metabolism in the liver
Vaginal estrogen Mostly local Targets vaginal dryness and genitourinary symptoms

Who Is Oral Menopausal Hormone Therapy Preferred For?

Oral hormone therapy may be preferred by some women because it is easy to use. However, because oral estrogen undergoes first-pass metabolism in the liver, it can have different effects on the clotting system and certain metabolic values than estrogen given through the skin.

For this reason, personal risk of blood clots, migraine, triglyceride levels, and other health characteristics may be taken into account when choosing the route of administration.

Transdermal Hormone Therapy: What Is the Difference Between a Gel and a Patch?

Gels and patches deliver estrogen into the bloodstream through the skin. Both are systemic treatments, but unlike oral estrogen, they largely bypass the first-pass effect in the liver.

Observational studies and clinical assessments suggest that transdermal estrogen may have an advantage over oral estrogen in terms of the risk of venous blood clots.

A gel can be applied daily, while a patch is changed at set intervals. The choice can be made based on personal preference, skin sensitivity, and individual risks.

What Is Vaginal Estrogen, and How Does It Differ From Systemic Hormone Therapy?

Vaginal estrogen can be used as a cream, gel, tablet, or ring. Low-dose local products are used especially for genital symptoms of menopause such as vaginal dryness, burning, and pain during intercourse.

With these products, the amount of hormone that enters the systemic circulation is generally much lower than with systemic treatments. For this reason, it is not accurate to group local vaginal estrogen together with the systemic hormone therapy used for hot flashes.

What Does Bioidentical Hormone Therapy Mean?

The term bioidentical hormone refers to hormones whose chemical structure is similar to the hormones produced in the human body. For example, estradiol and micronized progesterone can be considered part of this group.

However, the word bioidentical does not automatically mean that a product is safer or risk-free. In particular, a distinction must be made between custom mixtures compounded at a pharmacy and approved products that have undergone standardized dosing and quality control.

Who Should Not Receive Menopausal Hormone Therapy?

Hormone therapy is not suitable for every woman. Before treatment begins, personal and family history should be assessed in detail.

Situations in which systemic hormone therapy is generally not suitable or requires special evaluation may include:

  • A history of breast cancer or certain hormone-sensitive cancers
  • Unexplained vaginal bleeding
  • A previous deep vein thrombosis or pulmonary embolism
  • A history of stroke or significant cardiovascular disease
  • Active serious liver disease
  • Untreated endometrial conditions

In these situations, non-hormonal options or only certain local treatments may be considered instead of hormone therapy. The Menopause Society also lists a history of breast or uterine cancer, unexplained bleeding, liver disease, blood clots, and cardiovascular disease among the conditions that require special evaluation with regard to systemic hormone therapy.

What Are the Risks of Menopausal Hormone Therapy?

The risks of menopausal hormone therapy vary depending on the type of hormone used, the route of administration, the duration of treatment, age, and the woman's current health status. Not all hormone therapies carry the same level of risk.

The main risks taken into account are:

  • Breast cancer risk: With some combined estrogen-progestogen therapies, long-term use may be associated with a small increase in breast cancer risk.
  • Blood clot risk: Systemic estrogen taken by mouth in particular may increase the risk of venous blood clots in some women. Estrogen applied through the skin may have an advantage in this respect.
  • Stroke risk: This is assessed together with age, smoking, obesity, and existing cardiovascular risks.
  • Endometrial cancer risk: In women who have a uterus, using systemic estrogen alone can overstimulate the uterine lining. For this reason, progesterone or a progestin is usually added.

What matters here is not to view hormone therapy as either completely risk-free or inevitably dangerous. When the appropriate type of hormone, dose, and route of administration are chosen with personal risks in mind, treatment can be planned safely and effectively for many women.

What Checks Are Done Before Starting Menopausal Hormone Therapy?

Before hormone therapy, the woman's menopausal symptoms, date of her last period, current medications, smoking, and personal and family medical history are assessed. In particular, any history of breast cancer, blood clots, stroke, cardiovascular disease, and unexplained vaginal bleeding is asked about.

Basic health indicators such as blood pressure and weight are assessed. It is important that breast screening appropriate for the woman's age and screening program is up to date.

Is a Breast and Gynecological Evaluation Needed Before Hormone Therapy?

Breast screening should have been performed in line with the woman's age and risk profile. An additional mammogram is not automatically required for everyone before starting hormone therapy; the existing screening program and personal risk are taken into account.

If there is unexplained postmenopausal bleeding, its cause should be investigated before starting hormone therapy. When necessary, an ultrasound or endometrial evaluation may be performed.

Which Blood Tests May Be Ordered Before Hormone Therapy?

Not every woman needs the same broad hormone panel. For most women, menopause can be diagnosed based on age and menstrual history.

Depending on personal health status, blood sugar, a lipid profile, liver function tests, or other tests may be ordered. The goal is not to continually measure hormone levels but to assess any health problems that could affect safe planning of treatment.

How Long Is Menopausal Hormone Therapy Used?

There is no fixed duration of menopausal hormone therapy that applies to everyone. Whether to continue treatment is decided based on whether symptoms persist and on the woman's benefit-risk balance, which changes over time.

Smiling blonde woman in bed holding an alarm clock, explaining how long menopausal hormone therapy is used

For some women a few years may be enough, while others may need treatment for longer. As a woman gets older, the dose and route of administration may be reassessed.

Is the Duration of Hormone Therapy the Same for Every Woman?

No. The key factors that determine the duration of treatment are whether symptoms continue and whether the benefit of treatment outweighs the personal risks.

It should not be assumed that treatment must automatically be stopped at a certain age. With long-term use, regular checkups and reassessment are important.

How Is Menopausal Hormone Therapy Stopped?

Hormone therapy can be stopped suddenly or by gradually reducing the dose over time. Symptoms may come back with either approach.

Some women may find it easier to taper the dose gradually. If severe hot flashes return after treatment is stopped, the personal benefit-risk balance can be reassessed and a different plan made.

What Can Happen in the First 3 Months of Menopausal Hormone Therapy?

In the first months of treatment, some temporary symptoms may occur as the body adjusts to the new hormone levels. These may include breast tenderness, bloating, headache, or spotting-type bleeding.

Most of these symptoms may ease over time. However, heavy or persistent bleeding, especially bleeding that starts after menopause, should be evaluated.

What Are the Side Effects of Menopausal Hormone Therapy in the First Months?

In the first months, breast tenderness, abdominal bloating, mild fluid retention, headache, and irregular spotting may occur. Treatments containing progesterone can cause drowsiness or mood changes in some women.

The severity of side effects can vary depending on the type and dose of hormone used. If symptoms are significant, the dose or route of administration can be adjusted.

When Is the First Checkup After Starting Hormone Therapy?

The first checkup is usually scheduled within the first few months of treatment. At this visit, whether hot flashes have decreased, side effects, the bleeding pattern, and how easy the treatment is to use are assessed.

If the treatment is well tolerated, later checkups are planned according to personal health status. For symptoms such as new vaginal bleeding, sudden swelling in the leg, or chest pain, do not wait for your routine checkup date.

Frequently Asked Questions

Does Hormone Therapy Cause Weight Gain?

Menopausal hormone therapy has not been shown to cause significant weight gain on its own. Age, metabolism, loss of muscle mass, sleep, and lifestyle may play a bigger role in weight changes during menopause.

Should Menopausal Hormone Therapy Be a Pill or a Gel?

There is no single right route for every woman. In some women with additional risk factors for blood clots, estrogen applied through the skin may be more suitable. The choice is made based on personal health status.

Does Menopausal Hormone Therapy Cause Cancer?

The risk varies depending on the type of hormone used, the duration of use, and personal health characteristics. Combined estrogen-progestogen therapy and estrogen alone are not assessed the same way. For this reason, risk should be considered on an individual basis.

Can Hormone Therapy Be Started Years After Menopause?

It can, but starting systemic therapy for the first time after age 60 and more than 10 years after menopause requires a more detailed risk assessment.

How Long Can Vaginal Estrogen Be Used?

Vaginal dryness and genitourinary symptoms can persist for a long time. Low-dose local vaginal estrogen can be used long term after an assessment of the individual's situation, and it is considered differently from systemic hormone therapy.

Can Menopausal Hormone Therapy Be Stopped Abruptly?

Treatment can be stopped abruptly or the dose can be tapered gradually. With either approach, hot flashes may come back. The way treatment is stopped can be decided based on the severity of symptoms and the woman's preference.

Is Menopausal Hormone Therapy Right for Every Woman?

No. Hormone therapy can be effective for many women with significant menopausal symptoms, but other options are considered in conditions such as breast cancer, blood clots, certain cardiovascular diseases, serious liver disease, or unexplained vaginal bleeding.